45 mm Device
Widely used in routine GI and colorectal procedures.
+91 9425150513 (Asia) support@24lifesciences.com
Size, Share & Industry Analysis, By Type (45 mm Device, 65 mm Device, Other Sizes), By Application (Gastrointestinal Surgery, Cardiovascular Surgery, Other Surgical Uses), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Surgical Centers), By Procedure (Colorectal Anastomosis, Upper GI / Bariatric Procedures, Vascular / Other Procedures), By Sales Channel (Direct Hospital Sales, Surgical Distributors, Integrated Contracting), and Regional Forecast, 2026-2034
The global Purstring autosuture purse string device market was valued at USD 132.9 million in 2025 and is estimated at USD 143.3 million in 2026. The market is projected to reach USD 215.0 million by 2034, representing a 5.2% CAGR during 2026–2034.
Purstring autosuture purse string devices are single-use instruments designed to place a circumferential purse-string suture quickly around hollow viscera or vascular structures. They are closely associated with gastrointestinal anastomosis preparation and selected cardiovascular procedures.
Demand follows colorectal, bariatric, upper gastrointestinal and other procedures that use circular staplers or require standardized circumferential closure. Disposable formats help reduce reprocessing and support consistent tissue capture and suture placement.
Hospitals compare device size, firing consistency, tissue access, suture security, compatibility with broader stapling systems and total procedure cost when standardizing products.
| Scope | Coverage |
|---|---|
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026–2034 |
| Market Measurement | Revenue, USD million |
| By Type | 45 mm Device; 65 mm Device; Other Sizes |
| By Application | Gastrointestinal Surgery; Cardiovascular Surgery; Other Surgical Uses |
| By End User | Hospitals; Ambulatory Surgical Centers; Specialty Surgical Centers |
| By Procedure | Colorectal Anastomosis; Upper GI / Bariatric Procedures; Vascular / Other Procedures |
| By Sales Channel | Direct Hospital Sales; Surgical Distributors; Integrated Contracting |
| By Region | North America; Europe; Asia-Pacific; Latin America; Middle East & Africa |
The market includes disposable autosuture purse-string devices with integrated suture-placement functionality.
Reusable manual purse-string clamps, generic sutures and unrelated staplers are outside the core revenue boundary.
Colorectal resection and circular anastomosis create recurring use.
Single-use systems simplify OR setup and consistency.
Stapled reconstruction supports accessory device use.
Large systems increasingly standardize surgical platforms.
Hand-sewn purse strings remain a low-cost substitute.
Hospitals prefer compatible accessories within one stapling platform.
45 mm and 65 mm formats simplify inventory.
Time-saving devices remain attractive in busy ORs.
Hospital modernization expands demand.
Reliability and OR time matter alongside unit cost.
Modern devices combine mechanical tissue capture with preloaded suture placement to standardize a manual surgical step.
Parallel Jaw / Staple Mechanism
Captures a controlled tissue circumference.
Integrated Suture Delivery
Reduces setup and supports repeatable placement.
45 mm and 65 mm Formats
Matches common surgical anatomy.
Single-Use Sterile Supply
Simplifies OR logistics.
The market is segmented into 45 mm, 65 mm and other sizes. The 45 mm device leads because it fits a broad range of GI procedures.
Widely used in routine GI and colorectal procedures.
Supports broader tissue circumference.
Serve niche anatomy and surgeon preference.
The 45 mm segment should remain the largest through the forecast period.
The market is segmented into gastrointestinal surgery, cardiovascular surgery and other uses. GI surgery dominates.
Colorectal and upper-GI anastomosis preparation drives demand.
Selected vascular procedures use purse-string closure.
Used where circumferential tissue control is needed.
Gastrointestinal surgery will remain the largest application.
Hospitals, ASCs and specialty centers form the main end-user groups. Hospitals lead.
Manage most complex GI and cardiovascular procedures.
Selected procedures continue shifting outpatient.
Focused GI and cardiovascular activity supports demand.
Hospitals will remain dominant, with ASCs adding incremental growth.
By procedure, colorectal anastomosis leads, followed by upper-GI or bariatric procedures and vascular or other uses.
Frequently requires purse-string preparation for circular stapling.
Selected reconstructions use circumferential closure.
Used around access or tubular structures.
Colorectal anastomosis should remain the largest procedure segment.
Direct sales, distributors and integrated contracting shape commercialization. Direct and enterprise contracts lead value.
High-volume hospitals purchase directly.
Extend reach to smaller centers.
Bundles accessories with broader stapling platforms.
Integrated contracting should gain share among large health systems.
Regional demand follows colorectal surgery volume, OR modernization and disposable stapling adoption. North America is the largest market.
High surgical volumes and standardized stapling systems support demand. United States: Enterprise surgical contracting supports established vendors.
Stable colorectal surgery infrastructure supports recurring use.
Hospital modernization and rising GI surgery volumes support adoption. China & India: Expanding surgical capacity increases disposable device use.
Growth is concentrated in larger tertiary hospitals.
Premium adoption is concentrated in advanced surgical centers.
Commercial acceptance depends on sterile supply, mechanical reliability and compatibility with established operative technique.
Packaging and sterility must remain intact through distribution. Supports standardized OR use.
Firing and tissue-capture consistency are central to performance. Raises quality expectations.
Correct positioning affects suture security. Keeps surgeon familiarity important.
Field complaints inform quality systems and procurement. Supports vigilance.
The market is concentrated around established surgical-stapling companies, with smaller suppliers competing regionally and on price.
Medtronic
Broad GI surgery and stapling ecosystem supports bundled purchasing.
Johnson & Johnson MedTech / Ethicon
Competes through a broad anastomosis and stapling portfolio.
B. Braun / Aesculap, CITEC, CAK & Others
Compete through price and focused instrument portfolios.
2026: Market tracking continues to show 45 mm devices and GI surgery as leading categories.
2026: Major vendors continue emphasizing integrated stapling and anastomosis platforms.
Current procurement cycle: Enterprise surgical contracts increasingly bundle staplers, accessories and procedure-specific instruments.
Growth is expected to remain steady as colorectal and other stapled-anastomosis procedures expand and hospitals standardize disposable workflows. The market is estimated at USD 143.3 million in 2026 and projected to reach USD 215.0 million by 2034 at a 5.2% CAGR.
Colorectal surgery remains the core demand base. Supports recurring use.
Single-use systems simplify OR logistics. Supports penetration.
Bundled supply contracts reinforce installed vendors. Supports retention.
Hospital modernization broadens access. Adds growth.
Hand-suturing remains a substitute. Limits faster growth.
This report covers the purstring autosuture purse string device market across type, application, end-user, procedure and sales-channel segmentation, major regions, selected countries, competitive positioning, current developments and the 2026–2034 market outlook.
The analysis combines current market sizing evidence with surgical workflow and primary device-portfolio information. The displayed 2026 and 2034 values are consistent with a 5.2% CAGR.
The assessment emphasizes consistent market boundaries, current product evidence, primary regulatory or scientific sources, and arithmetic consistency across the displayed forecast values.
USD 132.9 million in 2025, USD 143.3 million in 2026 and USD 215.0 million by 2034.
The 45 mm device.
Gastrointestinal surgery.
North America.
They place a circumferential suture rapidly around hollow tissue or vascular structures.
They simplify sterile preparation and support consistency.
Medtronic, Ethicon, B. Braun/Aesculap and selected specialty suppliers.
Rising colorectal and minimally invasive surgery volumes.
2026–2034, with 2025 as the base year.
Medtronic — Surgical platform. current surgical-device ecosystem
Johnson & Johnson MedTech — Surgery portfolio. current stapling and surgery context
Review the report scope, forecast timeframe, methodology, and cited evidence before deciding whether the full study fits your requirement.
Coverage, segmentation, geography, and market boundaries are stated within the report.
Readers can review the published sources and evidence referenced in this market overview.
Base, estimated, and forecast years are shown to place the market outlook in context.
Each overview displays its report identifier and latest update date.
A structured view of market size, forecast outlook, segmentation, regional dynamics, competitive activity, and the research framework behind this study.
Review the market estimate, growth outlook, forecast direction, and key factors influencing future demand.
Understand the report’s defined segments, demand drivers, applications, end users, and market opportunities.
Assess regional performance, selected country context, and factors shaping adoption across major markets.
Explore company profiles, market positioning, and selected developments relevant to the market landscape.
Review key demand drivers, challenges, emerging opportunities, technology shifts, and factors influencing market direction.
Understand the report scope, market boundaries, research approach, and evidence referenced in the published market overview.